Clinically, there are many therapeutic options for overweight and obese women with PCOS, such as metformin (MET), glucagon-like peptide 1 receptor agonist, and orlistat, which can reduce weight, improve IR, and thus improve hyperandrogenemia and ovulation disorder. The gene discussed is GLP1R; the disease is polycystic ovary syndrome.